Delving into the Latest Updates on Zhejiang Youya Biotechnology Co., Ltd. with Synapse

Overview

This clinical trial is set out to evaluate the safety and efficacy of allogeneic human dental pulp mesenchymal stem cells in the treatment of severe pneumonia caused by COVID-19; to explore the effects of human dental pulp mesenchymal stem cells in the treatment of severe pneumonia of COVID-19 in terms of reducing mortality and improving clinical prognosis; and to discover a new therapeutic strategy for COVID-19 using allogeneic human dental pulp mesenchymal stem cells.

Start Date06 May 2020

Sponsor / Collaborator

Wuhan University People's Hospital

[+2]

100 Clinical Results associated with Zhejiang Youya Biotechnology Co., Ltd.

Login to view more data

0 Patents (Medical) associated with Zhejiang Youya Biotechnology Co., Ltd.

Login to view more data

100 Deals associated with Zhejiang Youya Biotechnology Co., Ltd.

Login to view more data

100 Translational Medicine associated with Zhejiang Youya Biotechnology Co., Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

1

Login to view more data